# OnCo record checkmate-067 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/checkmate-067/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "checkmate-067", "NCT01844505" ;
  schema:name "CheckMate 067"@en ;
  schema:description "The trial with the longest immunotherapy follow-up: about half of patients on the combination are alive at 10 years."@en ;
  schema:url <https://onco.cc/trials/checkmate-067/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01844505> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2013-06-11" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:people <https://onco.cc/people/dirk-schadendorf/>, <https://onco.cc/people/jedd-wolchok/>, <https://onco.cc/people/paolo-ascierto/>, <https://onco.cc/people/michael-postow/>, <https://onco.cc/people/f-stephen-hodi/>, <https://onco.cc/people/james-larkin/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-checkmate-067-10-year-nejm-2025/> .